# Core D:  University of Kentucky Alzheimer's Disease Core Center

> **NIH NIH P30** · UNIVERSITY OF KENTUCKY · 2021 · $285,735

## Abstract

Project Summary/Abstract: Neuropathology Core
The overall objective of the Neuropathology Core of the UK-ADRC is to support research on normal brain
aging, presymptomatic AD, MCI, early and late AD, mixed dementia syndromes, and other dementing
disorders. Autopsies will be performed by our Rapid Autopsy Team on longitudinally followed subjects from our
Clinical Core. We will perform short post-mortem interval autopsies, and we will maintain a high autopsy rate.
This Core is optimally tailored to help address important research questions. The Core will provide brain tissue,
CSF and other biospecimens for investigators at UK, other ADRCs, and outside investigators. The Core will
also provide consensus conference determined diagnoses, quantitation of neurofibrillary tangles, neuritic
plaques, and diffuse plaques from 8 brain regions, Ab quantitation, Braak staging, CERAD, and NIA-Reagan
Institute staging on all autopsied cases, along with evaluation of alpha-synuclein and TDP-43 proteinopathy.
This brain bank has been operating continuously for over three decades with a strong track record, so special
care will be taken to ensure diagnostic excellence, consistency, and continuity. The Core will maintain a tissue
bank of the above specimens and frozen serum, plasma, buffy coats and CSF from living patients. Special
emphasis will be placed on generating rigorous quantititative pathologic metrics from digital pathology, and
providing investigators with specimens from cognitively intact control subjects with no Ab deposition and
sparse tau pathology (successful cerebral aging) and many cases with mixed pathologies. Providing these
samples will contribute to clinical-pathological correlation studies and cutting-edge research that include
sponsored studies related to AD genomics, oxidative stress, hippocampal sclerosis/LATE, dementia with Lewy
bodies, Down syndrome, and neuroinflammation. Frequent consensus conferences will be held with the
Clinical, Biomarker, and Data Management and Statistics Cores to help define clinical-pathological diagnoses
on all autopsied subjects. The Neuropathology Core is strongly integrated with other Cores of the UK-ADRC,
and exploits unique opportunities to conduct clinical-pathological correlative studies on longitudinally followed
subjects. Through these methods we will better understand normal brain aging and the transition to multi-
etiology dementia with the goal of contributing to therapeutic or preventive measures. The Neuropathology
Core complements the other Cores of the UK-ADRC to provide extremely essential diagnoses and tissue
samples that are required for many cutting-edge researchers at the University of Kentucky and elsewhere. We
will build on our track record of excellence using innovative tools related to brain autopsies, neuropathological
diagnoses, tissue banking, and clinical-pathological correlation. Our specific aims are:
Aim 1: Provide state-of-the-art neuropathological and biospecimen repository serv...

## Key facts

- **NIH application ID:** 10261965
- **Project number:** 1P30AG072946-01
- **Recipient organization:** UNIVERSITY OF KENTUCKY
- **Principal Investigator:** PETER T. NELSON
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $285,735
- **Award type:** 1
- **Project period:** 2021-08-01 → 2026-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10261965

## Citation

> US National Institutes of Health, RePORTER application 10261965, Core D:  University of Kentucky Alzheimer's Disease Core Center (1P30AG072946-01). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10261965. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
